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Renal expression of genes that promote interstitial inflammation and
fibrosis in rats with protein.overload proteinuria. Rats with significant
proteinuria induced by daily injections of bovine serum albumin develop
interstitial inflammation and fibrosis. The present study was designed to
investigate the molecular basis of interstitial monocyte (Mø) recruitment
and early interstitial fibrosis. Groups of rats were sacrificed after one, two
and three weeks. Despite an increase in interstitial Mø at week 1, whole
kidney mRNA levels were not elevated for monocyte chemoattractant
protein-i (MCP-1), osteopontin or vascular cell adhesion molecule-i
(VCAM-i). Only osteopontin mRNA levels were significantly elevated in
the renal cortex at four days. At two and three weeks, MCP-1 and
osteopontin mRNA levels were increased and the proteins showed distinct
tubular patterns of distribution. By immunostaining increased expression
of VCAM-i and intercellular adhesion molecule-i (ICAM-i) was re-
stricted to their presence or the surface of the interstitial inflammatory
cells. TGF-j31 mRNA levels were increased at weeks 1, 2 and 3 (2.1, 2.9,
3.6x); interstitial and occasional cortical tubular cells expressed TGF-/31
mRNA and protein. There was a progressive rise in the number of cortical
interstitial fields with increased staining for collagen (col) 1(18, 29, 44%),
col III (39, 61, 63%), col IV (7, 13, 29%), laminin (4, 10, 30%), fibronectin
(14, 28, 37%), tenascin (19, 22, 14%) and in total renal col measured
biochemically (1.1, 1.4, 2.Ox) at weeks 1, 2 and 3, respectively. Renal matrix
protein mRNA levels were variable and not always predictive of fibrosis.
Only col I and tenascin levels were increased at week 1; all matrix protein
mRNA levels except col IV were increased at week 2; but only tenascin,
laminin and col IV mRNA levels remained elevated at three weeks.
Plasminogen activator inhibitor-i (PAl-i) and tissue inhibitor of metallo-
proteinases (TIMP)-i mRNA levels were significantly increased at two
weeks. During the three weeks there was no change in urokinase,
stromelysin or TIMP-3 mRNA levels. These results suggest that both
increased matrix protein synthesis and altered matrix remodeling/degra-
dation contribute to the final interstitial fibrogenic process in rats with
protein-overload proteinuria. Mø, one of the sources of TGF-3i, infiltrate
the interstitium by complex recruitment mechanisms which may depend in
part on osteopontin, ICAM-i and VCAM-i expression.
Background
Virtually all progressive renal diseases are characterized histo-
logically by an interstitial infiltrate of mononuclear cells and by
the gradual destruction of the normal tubulointerstitial architec-
ture due to the accumulation of extracellular matrix proteins
within the interstitial space. In numerous studies, the extent of
chronic tubulointerstitial damage has been the best histologic
correlate of the decline in glomerular filtration and the single best
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predictor of long-term renal outcome. In this study, we used the
rat model of protein-overload proteinuria to investigate the
molecular basis of interstitial monocyte recruitment and the early
phase of matrix protein accumulation within the renal intersti-
tium. This is a non-immunologic model of renal disease that is
characterized by early and impressive interstitial inflammation [1].
Interstitial fibrosis develops two to three weeks after the onset of
nephrotic range proteinuria. The protein-overload proteinuria
model has proven to be a valuable model to investigate the
relationship of proteinuria to acute tubulointerstitial injury.
Current evidence suggests that inflammatory interstitial cells
play an active role in interstitial fibrogenesis primarily due to their
ability to synthesize fibrosis-promoting cytokines such as trans-
forming growth factor beta-i (TGF-/3i). For example, experimen-
tal manipulations designed to decrease the interstitial influx of
monocytes during the acute phase of puromycin aminonucleoside
nephrosis (systemic irradiation [2], dietary essential fatty acid
deficiency [3], prednisolone therapy [4], and dietary protein
restriction [5]) have all been effective in reducing the severity of
interstitial fibrosis. Interest has now begun to focus on the
molecular basis of monocyte recruitment, a complex process that
involves chemoattraction and cellular adhesion events. The ex-
pression of four candidate molecules was investigated in the
present study: monocyte chemoattractant protein-i (MCP-1),
osteopontin, vascular cell adhesion molecule-i (VCAM-i) and
intercellular adhesion molecule-i (ICAM-i),
MCP-1, a member of the intercrine supergene family, is a
glycoprotein with monocyte-specific chemoattraction properties
[6. Its expression can be induced in renal tubular cells and in
monocytes themselves following exposure to a variety of cytokines
[6—8]. Osteopontin, a glycoprotein that was originally isolated as
a bone matrix molecule, has monocyte chemotactic effects [9].
Recent studies suggest a partial association between tubular
expression of osteopontin and a macrophage-rich interstitial
infiltrate in rats with anti-Thy-i glomerulonephritis, puromycirl
aminonucleoside nephrosis, passive Heymann nephritis [10 and
in rats with angiotensin Il-induced hypertension [lii.
131 and /32 integrin receptors mediate the adherence of mono-
cytes to endothelial cells, an interaction that is facilitated by
selectin-mediated tethering of the circulating cells [12]. Very late
antigen-4 (VLA-4; a4/31) binds monocytes to VCAM-i [13—15].
VCAM-1 is normally expressed by peritubular capillaries as well
as renal tubules [16—20]. Tubular expression of VCAM-1 has been
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correlated with the number of transferrin-receptor-positive inter-
stitial cells in humans with primary glomerulonephritis [211. A
biologically significant role for VLA-4 interactions with VCAM-l
in interstitial renal disease is suggested by the ability of anti-
VLA-4 antibodies to prevent interstitial disease in rats with
mercuric chloride-induced nephritis [22]. The /32 or leukocyte
integrins (CD11/CD18 complex) bind to ICAM-1 that is normally
expressed on interstitial cells and vessels. Up-regulated renal
ICAM-1 expression has been reported in a variety of kidney
diseases, both in human and animal models. A biologically
significant role for ICAM-1 in interstitial renal disease is sug-
gested by the ability of anti-ICAM-1 antibodies to attenuate
interstitial nephritis in renal allograft rejection [23], in autoim-
mune anti-GBM nephritis [241 and in the kdkd strain of mice with
autoimmune interstitial nephritis [25]. VCAM-1 and ICAM-1
may also be expressed by mononuclear cells.
The second objective of this study was to gain insight into the
molecular basis of the early phase of interstitial fibrosis in the
model of protein-overload proteinuria. TGF-/31 elicits a variety of
responses that promote interstitial fibrosis and it may also func-
tion as a monocyte chemokine to amplify the inflammatory
response. TGF-/31 has been implicated as an important fibrogenic
cytokine during fibrosis of several organs. Within the kidney,
glomeruloscierosis has been linked with over-expression of
TGF-f31 [26—29], while its role in interstitial fibrosis has been
proposed but not yet proven. Both interstitial macrophages [301
and tubular epithelial cells [31] are a potential source of TGF-j31,
and their relative importance as a source of augmented synthesis
during interstitial fibrosis remains to be determined.
Two distinct processes may mediate renal fibrosis and at the
present time their relative contribution is unclear. The first, and
currently the most commonly implicated mechanism is an increase
in the rate of matrix protein synthesis. This process may involve
the de novo synthesis of matrix proteins not normally expressed in
the renal interstitium. The second possibility is that renal fibrosis
is due to the inhibition of matrix turnover. The kidney is capable
of producing a number of proteases, several of which have
specificity for matrix proteins. The recent recognition of protease
inhibitors within the kidney [32] and increased expression of genes
encoding these inhibitors in several models of progressive renal
disease suggest a mechanism whereby alterations in matrix turn-
over could make an important contribution to progressive renal
scarring. The renal expression of three protease inhibitors was
investigated in this study: tissue inhibitor of metalloproteinase-1
(TIMP-1), TIMP-3 and plasminogen activator inhibitor-I (PAl-
1).
TIMP-1 is a glycoprotein that is produced by virtually all
mesenchymal tissues including intrinsic glomerular cells, inflam-
matory cells such as macrophages and fibroblasts [33, 34]. TIMP-1
inactivates interstitial collagenase (that degrades collagens I, II
and III), the latent 92 kDa gelatinase (that degrades non-helical
collagens type IV and V and denatured interstitial collagens) and
stromelysin (that degrades a variety of substrates including colla-
gens IV, V, VII, denatured collagen I, laminin, fibronectin and
also procollagenases). TIMP-3 protein was isolated from Rous
sarcoma virus transformed chick embryo fibroblasts, and was
proposed as the third member of the TIMP family in 1992 based
on cloning and sequencing data [35]. Its enzyme specificities have
not yet been determined. The human homologue has recently
been cloned [36]. In a survey of tissue-specific TIMP-3 expression
in normal mice, the highest mRNA levels were found in the
kidney [371.
PAl-i is thought to be the major physiological inhibitor of
circulating plasminogen [38]. In the absence of PAl-i, the serine
protease plasmin can be generated by proteolytic cleavage of
plasminogen. Although plasmin is widely recognized for its func-
tion in the coagulation cascade, it is also thought to play an
important role in matrix turnover. Not only does plasmin activate
latent metalloproteinases, but it also directly degrades many
matrix proteins.
Methods
Experimental design
Female Lewis rats weighing 100 to 120 g were purchased from
Charles River Breeding Laboratories (Wilmington, MA, USA).
They were fed standard rat chow ad libitum and given free access
to water. Rats underwent a left nephrectomy five days before the
initiation of intraperitoneal (i.p.) injections. Experimental rats
were given 1.0 g bovine serum albumin (BSA No. A-7906,
98—99% albumin; Sigma Chemical Company, St. Louis, MO,
USA) dissolved in saline i.p. daily. Control animals were injected
daily with an equivalent volume of saline.
Rats were housed individually in metabolic cages and timed
collections of spontaneously voided urine were collected for the
24-hour period prior to sacrifice. Groups of rats (4 control and 4
experimental animals) were sacrificed after one, two and three
weeks of intraperitoneal injections. Animals were killed by com-
plete exsanguination under general anaesthesia by inhalation of
nitrous oxide, oxygen and enflurane (Anaquest, Pointe Claire,
Quebec, Canada). At the time of death the remaining kidney in
each rat was decapsulated and carefully weighed (wet wt). The
kidney was bivalved and one section was snap frozen in liquid
nitrogen for extraction of total RNA. The second half was divided
into two parts: the first part was carefully weighed and frozen in
liquid nitrogen for total collagen measurements. The second
portion was divided into smaller pieces of cortex that were snap
frozen in isopentane pre-cooled in liquid nitrogen for subsequent
immunostaining. All tissues were stored at —70°C.
A second study of 12 animals was performed to evaluate gene
expression restricted to the renal cortex. An identical animal
protocol as outlined above was followed and groups of animals (N
= 3 controls, 3 BSA-injected) rats were sacrificed on day 4 and
day 7. The renal capsule was removed, the medulla was carefully
dissected away and the remaining cortex was stored for RNA
extraction.
Urinaiy protein excretion
Total urinary protein was measured in the urine collections
obtained prior to sacrifice using the Bio-Rad protein assay
(Bio-Rad Laboratories Canada Ltd., Mississauga, Ontario, Can-
ada). Results were expressed as total protein/100 g body wt
normalized to a 24-hour collection period.
Renal immunofluorescence studies
The number of interstitial monocytes/macrophages expressing
the cytoplasmic marker ED-i (Serotec, Oxford, UK) [39] was
quantified on acetone-fixed 3 p-thick cryostat kidney sections with
the dual fluorochrome labeling and enumeration technique that
we have previously described [40]. Tissue sections from all study
1548 Eddy et al: Interstitial inflammation and renal fibrosis
animals were evaluated by indirect immunofluorescence staining
for the pattern of expression of MCP-1 (rabbit anti-rat MCP-1
antiserum, gift of Dr. J.S. Warren, University of Michigan Medical
School) [41, 42], osteopontin (goat anti-rat smooth muscle os-
teopontin) [43], ICAM-i (anti-rat ICAM-i monoclonal antibody,
Cedarlane Laboratories Ltd., Hornby, Ontario Canada),
VCAM-l (anti-rat VCAM-i monoclonal antibody, gift of Dr. P.
Chishoim, Biogen, Cambridge, MA, USA) [441 and TGF-pi
(rabbit anti-TGF-1 {anti-LC} antibody, gift of Dr. K. Flanders,
National Institute of Health, Bethesda, MD, USA) [45]. To
evaluate tubular osteopontin expression in relationship to inter-
stitial macrophages and regenerating tubules expressing the inter-
mediate filament vimentin [46], kidney sections were stained
simultaneously for osteopontin using the goat anti-osteopontin
antibody followed by fluorescein isothiocyanate (FITC)-conju-
gated rabbit anti-goat IgG (Organon Teknika Corp., West Ches-
ter, PA, USA) and murine monoclonal anti-ED-i antibody or
murine monoclonal anti-vimentin antibody (ESBE Laboratory
Supplies, Markham, Ontario, Canada), respectively. The murine
monoclonal antibodies were detected by secondary staining with
7-amino-4-methylcoumarin-3-acetic acid (AMCA)-conjugated
goat anti-mouse IgG (Jackson Immunology Research Laborato-
ries Inc., West Grove, PA, USA). The accumulation of extracel-
lular matrix proteins within the tubulointerstitial compartment of
the kidney was assessed semiquantitatively with fluorescence
microscopy, using the technique the we have previously described
[47]. The primary antibodies used were sheep anti-human colla-
gen I, goat anti-human collagen III, goat anti-human collagen IV
(Southern Biotechnology Associates, Birmingham, AL, USA),
rabbit anti-human tenascin (gift from Dr. H. Erickson, Duke
University, North Carolina USA) [481, rabbit anti-murine laminin
(Dimension Laboratories Inc., Mississauga, Ontario, Canada) and
murine monoclonal antibody to human fibronectin EDA (gift of
Dr. L. Zardi, Instituto Nazionale perla Rererca sul Cancro, Italy)
[49]. Selected renal tissue was stained with rabbit anti-bovine
TIMP (gift of YA De Clerck, Children's Hospital of Los Angeles,
Los Angeles, CA, USA) 150], and rabbit anti-murine PAT-i, (gift
of Dr. D. Loskutoff, The Scripps Research Institute, La Jolla, CA,
USA) [51]. The secondary antisera were fluorescein isothiocya-
nate (FITC)-conjugated rabbit anti-sheep IgG, FITC-conjugated
rabbit anti-goat IgG, or FITC-conjugated goat anti-rabbit IgG
antiserum (Organon Teknika Corp., West Chester, PA, USA).
FITC-conjugated antisera were absorbed with normal rat plasma
and shown to be nonreactive with control kidney sections. The
investigator was blinded to the animal group at the time these
investigations were performed.
Gene-expression studies
Total cellular RNA was isolated according to the guanidinium-
isothiocyanate/cesium chloride method of Chirgwin et al [52], and
Northern blotting was performed according to standard methods.
In brief, 20 g of total kidney RNA from each individual animal
was loaded into a 1.0% agarose formaldehyde gel, separated by
electrophoresis, transferred to a nylon membrane, and fixed by
ultraviolet cross-linking (Stratalinker TM, Stratagene, La Jolla,
CA, USA). Complementary DNA were radiolabeled with 32P
dCTP (3000 Ci/mmol) by random priming with the T7 DNA
polymerase Quick Prime kit (Pharmacia LKB, Baie L'Urfe,
Quebec, Canada). Following prehybridization, the membranes
were hybridized with the radiolabeled probe using QuikhybTM
rapid hybridization solution (Stratagene). Autoradiographs were
obtained and the bands quantified by laser densitometry (Ul-
troscan XL Enhanced Laser Densitometer, Pharmacia LKB Bio-
technology). The negative images of the photographs of the
formaldehyde gels stained with ethidium bromide were also
scanned for the density of the ribosomal band (that is, 28S or 18S)
that was most closely associated with the mRNA signal of interest
to quantitate the amount of RNA loaded onto the gel. The density
reading of each band on the autoradiograph was adjusted for any
RNA-loading inequality, as we have previously described [47, 53].
cDNA probes
The cDNA probes used were rat MCP-1 (gift from Dr. T.
Yoshimura, National Cancer Institute, Bethesda, MD, USA) [54],
rat osteopontin [55], murine ICAM-i (gift from Dr. A. Brain,
University of California, San Diego, CA, USA) [56], rat VCAM-i
(gift from Dr. T. Collins, Harvard Medical School, Boston, MA,
USA) [57], rat TGF-31 (supplied by Dr. S.W. Qian, National
Cancer Institute), rat al(I) procollagen (supplied by Dr. S.
Thorgiersson, National Cancer Institute), murine ai(III) procol-
lagen (supplied by Dr. Y. Yamada, National Institute of Health),
rat fibronectin lambda-rlf-i (supplied by Dr. R. Hynes, Center for
Cancer Research, Massachusetts Institute of Technology, Cam-
bridge, MA, USA), mouse tenascin (supplied by Dr. P. Ekblom,
Uppsala University, Sweden) [58, 59], murine probes for a2(IV)
procollagen pPE18 and laminin Bi pPE386 (supplied by Dr. M.
Kurkinen, University of New Jersey-Rutgers Medical School,
Piscataway, NJ, USA), murine TIMP-1 (supplied by Dr. D.T.
Denhardt, Rutgers University), murine TIMP-3 (supplied by Dr.
R. Khokha, London Regional Cancer Centre, London, Ontario)
[37], rabbit stromelysin pSi2 (supplied by Dr. Z. Werb, University
of California, San Francisco), rat urokinase-type plasminogen
activator (tPA) (supplied by Dr. J. Degan, Children's Hospital
Research Foundation, Cincinnati, OH, USA), and rat PM-i
(supplied by Dr. Z.R. Gelehrter, The University of Michigan, Ann
Arbor, MI, USA) [59]. Unreferenced probes are cited in our
previous publications [5, 47, 53].
TGF-131 in situ hybridization
Sections of paraformaldehyde-fIxed, parafin-embedded kidney
sections (5 t thick mounted on sialinate-treated glass slides) from
day 7 control and BSA-treated rats were subjected to in situ
hybridization with a digoxigenin-labeled rat TGF-pi cRNA
probe. A full length rat TGF-131 complementary DNA cloned into
the pBluescript II KS + transcription vector was provided by Dr.
Qian, National Cancer Institute). An anti-sense cDNA probe was
synthesized with T7 RNA polymerase following Hind III endo-
nuclease linearization and a sense cRNA probe was synthesized
with T3 RNA polymerase following linearization with XbaI
according to the manufacturer's instructions (DIG RNA labeling
mixture, Boehringer Mannheim, Laval, Quebec). The size of the
antisense riboprobe was shown to be the predicted 1.0 kb by
agarose formaldehyde gel electrophoresis.
Tissue sections were dewaxed and hydrated with decreasing
strengths of ethanol. Sections were pretreated in sequence with
0.2 N HC1 at room temperature for 10 minutes, proteinase K (iO
tgIml) at 37°C for 30 minutes and 0.3% Triton X-100 in 2)< SSC
(1 X SSC: iSO mivi NaCI, 15 m sodium citrate, pH 7.0) at room
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temperature for 10 minutes, and washed with diethylpyrocarbon-
ate treated water between each step. The sections were prehy-
bridized with 50% deionized formamide in 2 X SSC at 37°C for 60
minutes. Hybridization was performed overnight at 37°C with the
digoxigenin-labeled TGF-/31 cRNA probe (30 ngI3O d) dissolved
in the hybridization solution containing 50% formamide, 10 mrvi
Tris-HCI pH 7.6, 200 .tg/ml tRNA, 1 X Denhardt's solution, 10%
dextran sulfate, 0.6 mrvi NaC1, 0.2% SDS. The slides were covered
with Gelbond film (Mandel Scientific Company Ltd, Guelph,
Ontario) and placed in a sealed humidified chamber. Slides were
washed twice with 2 X SSC and twice with 1 X SSC at room
temperature and twice with 0.5 >< SSC at 37°C. Detection was
performed with anti-digoxigenin antibody conjugated to alkaline
phosphatase and nitroblue tetrazolium salt (NBT) as the enzyme
substrate (DIG Nucleic Acid Detection Kit, Boehringer Mann-
heim). Intrinsic alkaline phosphatase was blocked both by pre-
treatment with the manufacturer's blocking reagent that was
purified from thy milk powder and by adding 25 mivi levamisole
(Sigma Chemical Company) to the solutions containing the
antibody and NBT. Tissues were counterstained with methyl
green, dehydrated with ethanol, cleared in xylenes and mounted
in Entellan (BDH mc, Toronto, Ontario).
The specificity of the in situ hybridization was confirmed by
demonstrating the disappearance of hybridization signals when
RNAase (0.1 mg/mI) was added to the prehybridization solution
and by exchanging the antisense ribopobe for the sense ribopobe
in the hybridization solution.
Total renal collagen
Total renal collagen was measured biochemically. An accu-
rately weighed portion of the kidney, representing approximately
25% of the total kidney, was homogenized in distilled water and
hydrolyzed in an equal volume of 5.7 M HC1 by incubation at
110°C for 18 hours. The hydrolysate was dried by speed vacuum
centrifugation over five to six hours and redissolved in buffer (2.5
g citric acid, 6 ml glacial acetic acid, 60 g sodium acetate, and 17
g sodium hydroxide in 500 ml H20, pH 6.0). Total hydroxyproline
in this hydrolysate was determined by a chemical method based on
the technique of Kivirikko, Laitinen and Prockop [60]. Total
collagen in the tissue was calculated on the assumption that
Fig. 2. TGF-131 immunostaining using a polyclonal antibody against an
intracellular aminoterminal peptide of TGF-131. In the control kidney
TGF-131 is expressed by several intraglomerular cells, cells within vessel
walls (V) and by occasional tubules (A). In the protein-overload kidneys,
TGF-j31 positive cells appear within the interstitium (B) and increase in
number in glomeruli (not shown). (A, B X 230).
collagen contains 12.7% hydroxyproline by weight. Final results
were expressed as milligrams of collagen per kidney and were
based on the wet weight of the intact kidney.
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Fig. 1. Densitometric analysis of renal TGF-131
mRNA levels. Upper figure is the Northern blot
and the lower figure the ethidium bromide-
stained gel. The graph summarizes the results
of the densitometric analysis (mean SD)
expressed in arbitrary units after correction for
any uneven RNA loading. < 0.05, Student's
t-test.
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Fig. 3. In Situ hybridization analysis of renal TGF-pl mRNA expression in
rats with protein-overload proteinuria. In normal kidneys the TGF-f31
antisense riboprobe binds to occasional renal cortical tubules (A). After
one week of protein-overload proteinuria the TGF-j31 riboprobe binds to
many interstitial cells (B), while no binding is observed with the TGF-131
sense probe (C). (A—c X 240).
Table 1. Parameters of renal disease in rats with protein-overload
proteinuria
Proteinuria
mg/100 g body wt124 h
ED-i ÷ interstitial cells
per i000 TI cells
Controls 2 3 38 9
Week 1 87 80 87 16
Week2 75±8ia 103±23a
Week3 80±86a 85±18a
Statistical analysis
Results for experimental animals were compared with results
for control animals studied at the same time point (weeks 1, 2 or
3) using Student's t-test for independent means. A P value <0.05
was considered statistically significant.
Results
Transforming growth factor.f31
TGF-/31 mRNA levels were significantly elevated at weeks 1, 2
and 3 (Fig. 1). TGF-pi staining of the tubulointerstitium of
normal renal cortex was restricted to occasional cells within the
walls of blood vessels and rare tubular cells. TGF-pl immunos-
taming became associated with interstitial cells and occasional
tubular epithelial cells in rats with overload proteinuria (Fig. 2).
At three weeks approximately 6% of all cortical tubulointerstitial
nuclei were TGF-/31 positive interstitial cells in the rats with
Fig. 4. Densitometric analysis of renal mRNA levels for MCP-1, osteopontin
and VCAM-1. Results were initially expressed in arbitrary units after
correction for any inequality in RNA loading. Each bar in this figure
represents the ratio of the mean scores for protein-overload compared to
control rat kidneys. Symbols are: (LI) week 1; () week 2; (U) week 3.
'P < 0.05, Student's t-test, when the individual scores for the two groups
were compared at each time point (weeks 1, 2 or 3).
overload proteinuria while the corresponding number was 0% in
control rats. There was a significant positive correlation between
the number of interstitial macrophages and renal TGF-pl mRNA
levels (r = 0.63, P = 0.002).
Abbreviation TI is tubulointerstitial.
aP < 0.05, Student's t-test
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Fig. 5. Immunofluorescence photomicrographs illustrating the relationship of cortical tubular osteopontin expression both to tubular expression of vimentin
and to interstitial macrophages in rats with protein-overload proteinuria (week 3). Dual-staining the same kidney section for osteopontin (A) and the
macrophage marker ED-i (B) demonstrates the presence of interstitial macrophages (arrows) in close proximity to osteopontin-positive tubules.
Dual-labeling the same kidney section for osteopontin (C) and vimentin (D) demonstrates osteopontin expression by vimentin-positive tubules. "T"
identifies the same tubule in panels A and B. (A—D x 240).
The results of the in Situ hybridization analysis of renal TGF-pl
mRNA expression were consistent with the results of TGF-pl
immunostaining. In normal kidneys TGF-f31 mRNA was abun-
dantly expressed by tubular cells in the medulla while only a few
isolated tubules in the cortex were positive (Fig. 3A). After seven
days of overload proteinuria, a considerable number of interstitial
cells expressed TGF-/31 mRNA and there was an overall increase
in the number of tubules in the cortex expressing TGF-131 mRNA
(Fig. 3B).
Interstitial monocyte recruitment
Coincident with the onset of proteinuria, the interstitium was
infiltrated with a significant number of monocytes (Table 1). At
one week, despite the increased number of interstitial monocytes,
total kidney mRNA levels were not significantly increased for
MCP-1, osteopontin or VCAM-1 (Fig. 4). MCP-1 mRNA levels
were significantly increased at weeks 2 and 3. However, most of
the MCP-l protein detected by immunofluorescence microscopy
appeared as large granules resembling protein reabsorption drop-
lets, most notably within glomeruli but also within occasional
tubules, Control kidneys were negative for MCP-1 staining.
MCP-1 mRNA levels in isolated renal cortex were not signifi-
cantly different from controls at days 4 and 7 (data not shown).
Total kidney osteopontin mRNA levels were increased at weeks
2 and 3 although the difference was only statistically significant at
week 2. In normal kidneys osteopontin staining was restricted to
tubules in the medulla. For this reason a second study was
performed to evaluate osteopontin mRNA levels in the renal
cortex. On day 4 renal cortical osteopontin mRNA levels were
significantly increased in the kidneys of rats with overload pro-
teinuria (2.9 0.1 vs. 1.0 0.3 arbitrary units, P = 0.001). The
difference in cortical osteopontin mRNA levels was not statisti-
cally significant on day 7 (1.6 0.4 vs. 0.9 0.2 arbitrary units).
By week 1, 37 19% of the cortical interstitial fields contained
tubules that expressed osteopontin protein, either concentrated at
the apical membrane or distributed diffusely throughout the
cytoplasm (Fig. 5A and 5C). The percent positive fields remained
relatively constant at 41 28% and 40 6% at weeks 2 and 3,
respectively. By dual-labeling kidney sections for ED-i cells and
osteopontin, monocytes were identified adjacent to both os-
teopontin positive and negative tubules (Fig. 5A, B). Using
tubular vimentin expression as a marker of recent tubular injury,
it was noted that virtually all vimentin-positive cortical tubules
also expressed osteopontin (Fig. 5C, D). However, the converse
was not true with only 52% of osteopontin-positive tubules
simultaneously expressing vimentin.
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Fig. 6. Photomicrographs illustrating renal I/CAM-i and ICAM-i immunostaining. In control rat kidneys, VCAM-1 was present in the interstitium,
expressed by peritubular capillaries and interstitial cells (A). There was an increase in the number of VCAM-1 positive interstitial cells in rats with
overload proteinuria (B). In the normal kidney, ICAM-1 was expressed by peritubular capillaries and the brush border of some proximal tubules (C).
The number of ICAM-l positive interstitial cells increased in the proteinuric rats (D). (A x 290; B X 260; C, D X 230).
Fig. 7. Changes in renal interstitial matrix
proteins in rats with protein-overload proteinuria.
The results of Northern blot analysis of total
kidney mRNA (A) are presented as a single bar
that represents the ratio of the mean value for
the experimental group compared to the mean
value for the control group. B. The increased
matrix protein immunostaining in the cortical
interstitium. Symbols are: (LI) week 1; ()
week 2; (•) week 3. Each bar represents mean
so. 'P < 0.05, Student's t-test analysis of
individual results.
VCAM-1 mRNA levels also did not change significantly at
weeks 2 or 3. Analysis of renal cortical VCAM-1 mRNA levels at
four and seven days also showed no statistically significant differ-
ences (data not shown). In normal rats VCAM-l was expressed by
peritubular interstitial cells. (Fig. 6A). In the proteinuric rats
there was an increase in the number of interstitial VCAM-1
positive cells (Fig. 6B). Adequate hybridization to the murine
ICAM-1 eDNA probe could not be obtained to evaluate mRNA
levels. In normal kidneys, ICAM-1 protein was present on pen-
tubular capillaries and on the brush border of some proximal
tubular cells (Fig. 6C). In rats with overload proteinuria, the most
striking change was the expression of ICAM-1 on the infiltrating
interstitial cells (Fig. 6D).
Extracellular matrix proteins
Interstitial matrix proteins. After one week of overload protein-
uria renal mRNA levels were increased for al(I) procollagen and
tenascin but not for al(III) procollagen or fibronectin (Fig. 7).
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Control
mg/kidney
Protein-overload
mg/kidney
Week 1 6.3 0.7 6.9 0.6
Week 2 6.9 0.7 9.5 0.4k'
Week 3 6.7 0.5 13.4 4.2a
Despite this difference, there was a significant increase in the
number of interstitial fields with expanded interstitial staining for
collagen III and fibronectin EDA as well as collagen I and
tenascin (Fig. 7). Total kidney collagen was not significantly
increased at one week (Table 2).
After two weeks of overload proteinuria, renal mRNA levels
were elevated for all four interstitial matrix proteins evaluated,
and there was a further increase in the number of interstitial fields
with abnormal matrix protein staining (Fig. 7). Total kidney
collagen was significantly increased 1.4-fold compared to control
kidneys (Table 2).
At three weeks, interstitial matrix protein mRNA levels re-
mained elevated in the proteinuric rats, although only the levels
for tenascin remained statistically significant (Fig. 7). Interstitial
fibrosis was more severe at this time based on the number of
interstitial fields with increased staining for the various matrix
proteins (Figs. 7 and 8) and the twofold increase in total kidney
collagen (Table 2) compared to control kidneys.
Basement membrane proteins. Renal mRNA levels were signif-
icantly increased for laminin at weeks 2 and 3, and for collagen IV
at three weeks. Abnormal deposition of these proteins, primarily
within thickened tubular basement membranes (and within adja-
cent interstitial spaces to a limited degree) was evident by two
weeks and more advanced by three weeks (Table 3).
Matrix-degrading enzymes and inhibitors
A significant change was not observed at any time in renal
mRNA levels for uPA, stromelysin, or TIMP-3 (Table 4). PAl-i
mRNA levels were significantly increased at week 2 (Table 4, Fig.
9). By immunostaining, PAl-i protein was identified in a few
cortical tubules and in the wall of large vessels in the proteinuric
but not control kidneys. TIMP-1 mRNA levels were significantly
increased at week 2 (Table 4, Fig. 9). TIMP-1 immunostaining of
control kidneys was negative. In proteinuric animals, several
tubular protein droplets and debris in tubular lumina were
positive. In addition, there was patchy TIMP-1 staining in the
renal interstitium.
Gene expression in control rat kidneys
Since all animals were uninephrectomized prior to entry into
the study, the effects of uninephrectomy followed by daily i.p.
injections of saline were examined separately by loading RNA
samples from the saline-injected animals (weeks 1, 2 and 3) onto
a single blot. At weeks one, two and three there were no
significant differences in renal mRNA levels for TGF-f31 (1.0
0.2; 1.2 0.5; 1.2 0.3 arbitrary units), osteopontin (1.0 0.1;
1.0 0.1; 1.0 0.2 arbitrary units), fibronectin (1.0 0.3; 1.0
0.3; 0.8 0.2 arbitrary units), and TIMP-1 (1.0 0.2; 0.7 0.2;
1.1 0.3 arbitrary units).
Discussion
The results of the present study of rats with protein-overload
proteinuria as a model of progressive renal injury illustrates the
complexity of the interactions that are likely to contribute to the
process of progressive renal interstitial scarring in vivo. After
three weeks of overload proteinuria the total kidney collagen
content was twice that of the control kidneys. Analysis of the
significant changes in renal mRNA levels suggests that an increase
in both the rates of matrix protein synthesis and degradation
contribute to interstitial fibrosis in this model (Fig. 10). The
fibrogenic cytokine TGF-j31 is likely to play an important role.
Not only were TGF-f31 mRNA levels significantly increased
throughout the three-week study period, but an increase in
biologically active TGF-131 is suggested by the pattern of altered
gene expression in the kidneys exposed to overload proteinuria.
TGF-f31 in situ hybridization and immunostaining studies sug-
gested that interstitial cells and some cortical tubular cells were
the source of increased TGF-/31 production in the proteinuric
rats. TGF-131 is emerging as the pivotal fibrogenic cytokine in
several organ systems. Within the renal interstitium, increased
TGF-pl expression has been reported in association with inter-
stitial fibrosis in models of aminonucleoside nephrosis [5, 47, 53],
adriamycin-induced nephrosis [61], chronic anti-Thy-i glomeru-
lonephritis [29], passive Heymann nephritis [5], anti-GBM nephri-
tis [62, 63], obstructive uropathy [64] and in humans with AIDS-
associated nephropathy [65]. Although TGF-f31 blocking studies
will be necessary to clearly establish its role in interstitial fibrosis,
it is interesting that several genes that are involved in fibrosis and
that are known to be regulated by TGF-pl were up-regulated in
the kidneys of the proteinuric rats, including genes encoding
several extracellular matrix genes and the protease inhibitors
PAl-i and TIMP-1. TGF-f31 is also reported to have monocyte
chemotactic activities in vitro. [66]. However, it is noteworthy that
over-expression of TGF-f31 in glomeruli [671 and iliac arteries [68]
by gene transfer therapy resulted in significant fibrosis in the
absence of a mononuclear cell infiltrate. Thus the role of TGF-131
as a monocyte chemokine in vivo awaits confirmation.
Given that the cells of the monocyte/macrophage lineage
appear to play an active role in fibrogenesis, it is important to
determine the molecular basis of monocyte recruitment to the
renal interstitium. The results of the present study suggest that
osteopontin, VCAM-1 and ICAM-1 might play a role. De novo
expression of osteopontin by cortical tubular cells occurred early
in the course of protein-overload proteinuria, with 37% of cortical
interstitial fields containing osteopontin-positive tubules by one
week. Osteopontin mRNA levels were significantly elevated in the
cortex on day 4. The stimulus for osteopontin expression by
cortical tubules is unknown. It may represent a response of the
tubules to injury. In the present study all regenerating tubules
identified by vimentin positivity also expressed osteopontin. How-
ever, almost half of the osteopontin-positive tubules were vimen-
tin-negative, suggesting that stimuli unrelated to tubular injury
may also induce osteopontin. The ability of osteopontin to
mediate interstitial monocyte recruitment in this model will need
to be tested by specific blocking studies. In support of this
hypothesis, some interstitial monocytes were identified adjacent
to osteopontin-positive tubules. However, most of the osteopontin
protein was concentrated along the apical membrane or within the
tubular cytoplasm, locations that are inaccessible to mononuclear
Table 2. Total kidney collagen
Results are mean SD.
aP < 0.05, Student's t-test
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Fig. 8. Immunofluorescence photomicrographs of the interstitial matrix proteins fibronectin EDA + (A and B), and collagen I (C and D). Compared to
control kidneys (A and C) there is a significant increase in interstitial fibronectin (B) and collagen I (D) after 3 weeks of overload proteinuria (A x
224, B x 232, C x 236, D x 230).
Table 3. Renal basement membrane proteins in rats with protein-
overload proteinuria
Laminin Collagen IV
mRNA Protein mRNA Protein
(relative
levela)
(increased
stainingb)
(relative
levela)
(increased
stainingb)
Week 1 0.8 0% 0.7 1%
Week 2 1.4c 10% 1.0 13%
Week 3 2.0c 30% 1.5c 29%
a Renal mRNA levels are expressed as a ratio of the mean value (in
arbitrary densitometric units) for the experiment group compared to the
mean value for the control group
b Matrix protein accumulation is expressed as the number of cortical
interstitial fields (mean SD) with increased immunostainingC P < 0.05, Student's t-test
cells circulating in peritubular capillaries. The ability of tubular
cells to secrete osteopontin into the interstitial space has not yet
been demonstrated.
Based on several studies that support a crucial role for VCAM-
I/VLA-4 interactions in monocyte recruitment [16—2fl, we were
surprised to find that renal VCAM-i mRNA levels did not change
during the course of protein-overload proteinuria. However, the
number of VCAM-1 expressing interstitial cells increased in the
proteinuric rats. ICAM-1 is constitutively expressed by peritubu-
lar capillaries and on the apical membrane of rat proximal tubular
cells. The most striking change in the kidneys of rats with
protein-overload proteinuria was the influx of ICAM-1-positive
Table 4. Protease/protease inhibitor mRNA ratios in rats with protein-
overload proteinuria
uPA PAl-i Stromelysin TIMP-1 TIMP-3
Week 1 1.0 0.8 0.9 1.6 1.0
Week 2 1.2 2.P 0.9 2.6a 1.0
Week 3 0.8 0.8 0.7 1.4 0.9
Abbreviations are: uPA, urokinase-type plasminogen activator; PAT-i,
plasminogen activator inhibitor-i; TIMP, tissue inhibitor of metallopro-
teinases.
Results are expressed as the ratio of the mean values (in arbitrary
densitometric units) for proteinuric compared to control kidneys.
a P < 0.05 when results for individual animals at each time point were
analyzed by Student's t-test for independent means
interstitial mononuclear cells. Analogous to VCAM-1/VLA-4
interactions, it is possible that ICAM-1 helps to sustain the
interstitial infiltrate of mononuclear cells through interactions
with LFA-1 and Mac-i molecules present on the surface of
adjacent interstitial mononuclear cells.
Renal MCP-i mRNA levels were significantly increased at two
and three weeks, yet the MCP-i protein expression was limited to
granular deposits resembling protein reabsorption droplets. We
observed a similar pattern of altered MCP-i mRNA and protein
expression in rats with acute puromycin aminonucleoside nephro-
sis, and we were unable to attenuate interstitial nephritis by
treating rats with a neutralizing anti-rat MCP-i antiserum (Eddy
PAl-i —ø
28s —*
Control BSA
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Week 2
TIMP-1 —+
18s —ø
Week 2
et a!, manuscript submitted). Taken together, these observations
suggest that MCP-1 may not play a significant role in interstitial
monocyte recruitment in rats with protein-overload proteinuria.
After just two weeks of overload proteinuria significant inter-
stitial fibrosis had already developed. It was at this time point that
the renal expression of genes encoding several matrix proteins and
proteases inhibitors was maximally stimulated. One week later the
total kidney collagen content was twice that of control kidneys and
significant interstitial fibrosis was confirmed by immunostaining
for individual matrix proteins. At two weeks, renal mRNA levels
for the interstitial matrix proteins al(I) procollagen, fibronectin
and tenascin were significantly elevated in the proteinuric animals.
Similar observations support a role for increased matrix synthesis
in the interstitial fibrogenic reaction in rats with puromycin
aminonucleoside nephrosis [47, 53] and with obstructive uropathy
[69—71]. Since transcriptional regulation is the critical level of
control of the production of many matrix proteins, elevated
kidney mRNA levels likely indicate increased protein synthesis.
Increased rates of collagen synthesis have actually been shown in
renal cortical tissue isolated from rabbits with crescentic nephritis
[62], and increased rates of fibronectin synthesis have been
demonstrated in glomeruli isolated from rats with nephrotoxic
serum nephritis [72]. Increased expression of genes encoding the
basement membrane proteins laminin and collagen IV was also
observed in the kidneys of rats with overload proteinuria. By
immunostaining, both of these proteins appeared to accumulate
mainly within thickened tubular basement membranes.
Despite the relatively modest increases in renal mRNA levels
for several matrix proteins, the degree of interstitial fibrosis that
developed in the kidneys of rats with overload proteinuria was
impressive. This is best illustrated by the results for interstitial
collagen III. Although procollagen III mRNA levels were never
significantly different from controls, by immunostaining collagen
III protein was significantly increased in the renal interstitium of
all rats with proteinuria. This discrepancy suggested the possibility
that decreased degradation of interstitial matrix proteins also
contributed to the fibrogenic process. In experimental models of
interstitial fibrosis due to renal vein ligation or ureteric obstruc-
tion, striking 30- to 40-fold and 10-fold reductions, respectively, in
renal collagenolytic activity have been reported [73]. In the
present study TIMP-1 mRNA levels were significantly elevated at
two weeks and the de novo appearance of TIMP-1 protein within
the interstitium of the proteinuric animals was confirmed by
Duration of overload proteinuria
Fig. 10. Schematic summaly of the significant changes in the kidneys of rats
with protein-overload proteinuria for 1, 2 or 3 weeks. Symbols in the fourth
panel are: () Collagen I; (VA); Collagen IV; (VA) Fibronectin; ()
Tenascin; (LI) Laminin. Symbols in the fifth panel are: (•) TIMP-1; (VA)
PAl-i.
immunostaining. An increase in biologically active TIMP-1 within
the diseased kidneys should decrease the rate of degradation of
interstitial matrix proteins due to its ability to inactivate interstitial
collagenase, the latent 92 kDa gelatinase, and stromelysin. In the
present study, stromelysin was examined as a representative of the
matrix-degrading metalloproteinase enzymes and stromelysin
mRNA levels remained unchanged compared to control animals.
Therefore, at least at the mRNA level, one would predict a net
decrease in matrix turnover at this time period. Increased renal
TIMP-1 mRNA levels have been reported in association with
Fig. 9. Renal expression of protease inhibitors in rats with overload protein-
uria. Northern blot analysis revealed a significant increase in PAT-i and
TIMP-l mRNA levels at week 2. Results of the densitometric analysis are
presented in Table 4.
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interstitial fibrosis in rats with aminonucleoside nephrosis [5, 47,
53], passive Heymann nephritis [5], and obstructive uropathy [70].
Plasmin-dependent degradation of matrix proteins is thought to
play a role in tissue destruction and wound healing [38]. Recently
inhibition of plasmin activation by overexpression of PAl-i has
been reported in rats with anti-Thy-i glomerulonephritis and has
been proposed as a mechanism of progressive renal scarring [29,
74,]. In the present study, we observed a discrete increase in renal
PAl-i mRNA levels at two weeks, while the mRNA levels for the
PAl-i substrate, urokinase-type plasminogen activator were high
in control kidneys and unchanged in rats with overload protein-
uria. It is possible that decreased levels of renal interstitial
plasmin protease activity may have contributed to the fibrogenic
network at the two week period.
In summary, an in vivo study of the potential mechanisms of
progressive renal interstitial fibrosis based on a rat model of
protein-overload proteinuria highlighted several candidate path-
ways which likely interact together to permanently damage the
kidney. As in several other models of wound healing and tissue
fibrosis, TGF-f3i appears to play an important role. Since inter-
stitial macrophages are a potentially important source of TGF-131,
understanding the mechanism of tissue invasion by monocytes is
essential. The results of the present study suggest that a single
pathway working in isolation is unlikely to mediate interstitial
monocyte recruitment. Tubular expression of the monocyte che-
mokine osteopontin and the expression of ICAM-1 and VCAM-i
on the surface of the interstitial inflammatory cells were remark-
able in the present study. The twofold increase in kidney collagen
content after three weeks of overload proteinuria was associated
with changes in renal gene expression that suggest that both
increased matrix protein synthesis and reduced matrix degrada-
tion contribute to the final interstitial fibrogenic process.
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